Standard Value Valuation Returns Presentations / Research Contact Us
_______________________________ Industry Sector Global Region Exchange Traded Funds Major Funds - Holding Tutorial _______________________________ Best Risk Adjusted Worst Risk Ajusted Best Expected Worst Expected Sector Ranking Dividend _______________________________ REIT's Leverage Risk Convertible Bonds Investment Grade High Yield ADR Small Caps _______________________________ White Paper Disclaimer _______________________________	Drugs - Generic        Total Market Capitalization of All Firms 99079 mm                     Average Market Capitalization 24770 mm               Average Market to Model Ratio Weighted by Log of Market Cap 0.93               Standard Deviation of MM Ratio 0               Average Beta 0.97               Average EV To Revenue 3.21               Average Price To Free Cash Flow 10.82        Ticker Company Name Market To Model Market Cap ($ mm) EV to Revenue Price To FCF % Growth Beta As Of MYL Mylan N.V. 1.2 21,208 3.0 7.6 0 1.29 Mar 18 TEVA Teva Pharmaceutical Industries 1.1 21,512 2.4 4.4 -1 1.33 Mar 18 AGN Allergan PLC 0.8 51,554 4.8 9.9 7 1.11 Mar 18 RDY Dr Reddy Laboratories Ltd 0.6 4,805 2.6 21.4 3 0.15 Dec 17
	Standard Value | About us | Contact us     Copyright © 2003-2018 Rational Investing LLC ® | All Rights Reserved